1-3 of 3
Murat Aktas
Close
Sort by
Journal Articles

A Phase I Dose Finding Trial of MB-CART20.1 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Nadine Kutsch, Philipp Gödel, Udo Holtick, Anja Lohneis, Vladan Vucinic, Florentine Pia Altefrohne, Christin Schubert, Sandra Karitzky, Linda Hanssens, Mario Assenmacher, Iris Bürger, Murat Aktas, Peter Borchmann
Journal: Blood
Blood (2022) 140 (Supplement 1): 12980–12981.
https://doi.org/10.1182/blood-2022-168730
Published: 2022
Journal Articles

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Murat Aktas, Philipp Dresing, PhD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Rupert Handgretinger, MD
Journal: Blood
Blood (2016) 128 (22): 2172.
https://doi.org/10.1182/blood.V128.22.2172.2172
Published: 2016
Journal Articles

Age-Related Differences Between Unrestricted Somatic Stem Cells from Cord Blood and Bone Marrow Derived Mesenchymal Stroma Cells.

Amelie Pia Houben, Anja Buchheiser, Murat Aktas, Johannes Fischer, Peter Wernet, Gesine Koegler
Journal: Blood
Blood (2008) 112 (11): 1335.
https://doi.org/10.1182/blood.V112.11.1335.1335
Published: 2008